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Abstract: ADAMTS (a disintegrin and metalloprotease with thrombospondin motifs) proteinases degrade proteoglycans and thereby
have the potential to alter tissue architecture and regulate cellular function. Recent studies about the roles of these enzymes have
produced new perspectives for the molecular mechanisms behind regenerative biology with clinical potential to generate therapeutic
targets to resolve tissue injury. ADAMTS enzymes play an important role in the turnover of extracellular matrix proteins in various
tissues and their dysregulation has been implicated in disease-related processes such as inflammation and fibrosis. Increasing evidence
indicates that they may be of key significance in the physiological and pathological central nervous system. In this review, we summarize
what is currently known about the roles of ADAMTS proteins in tissue repair and regeneration as well as in the pathogenesis of other
important biological processes and diseases including arthritis, atherosclerosis, and cancer.
Key words: Regenerative biology, ADAMTS, extracellular matrix, nervous system, chronic disease

1. Introduction
Regeneration is the process of renewal and restoration of
damaged tissues with identical cells. It is also known as
the ability of the cleavage of cells replacing the damaged
tissues of the species ranging from bacteria to humans
(Goss, 1992). In mammals, some human organs (liver
and uterus) have the ability to regenerate themselves after
injury. The regeneration of tissues or organs impaired as
a result of many reasons such as congenital defects and
diseases involves a healing process of active tissue and
organs (Mimeault et al., 2007; Daar, 2013). The cells and
tissues damaged by injuries go into motion to initiate their
own healing processes. In healthy tissues, regeneration
and reparation of cells occur after practically any injury
that causes tissue destruction, and this is essential for
the survival of the organs (Daar, 2013). Frequently,
reparation consists of a combination of regeneration and
wound healing with the deposition of collagen. Moreover,
extracellular matrix (ECM) growth factors and cytokines
are critical for the healing process (Werner and Grose,
2003; Daley et al., 2008). This requires some knowledge
of ECM components and their functions as well as matrix
metalloproteinase and ADAMTS (a disintegrin and
metalloproteinase with thrombospondin motifs) to grasp
the mechanisms of healing and regeneration. ADAMTS
* Correspondence: drferah@gmail.com
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members, many of which bind to each other and modulate
ECM proteins, form a family having 19 members and
sharing many common features, and they are secreted out
of the cell (Apte, 2004). In this mini-review, we summarize
what is currently known about the roles of ADAMTS
proteases in tissue repair and regeneration as well as
their other important roles in biological processes. We
searched for English-language studies published between
June 2002 and May 2015 by using the MEDLINE/PubMed
and Google Scholar databases. In general, studies used as
references in this article were selected with an approach
based on a comprehensive literature review through April
2015. For each database, the review terms used were
‘ADAMTS’, ‘Extracellular matrix’, ‘Wound healing’, and
‘Regenerative or restorative biology’.
2. ADAMTS genes
ADAMTS constitutes a family of 19 secreted enzymes,
of which the first member, ADAMTS-1 (Figure 1), was
described in 1997 (Kuno, 1997). Members of this family
are widely seen in mammals and they engage in different
biological processes including ovulation, spermatogenesis,
coagulation, neurogenesis, and extracellular matrix
turnover (Reiss and Saftig, 2009). Furthermore, ADAMTS
genes and their enzymes are also involved in diverse
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Figure 1. Structure and schematic representation of the domain organization of ADAMTS-1 proteinase. ADAMTS-1 is
composed of a propeptide, a metalloproteinase domain, a disintegrin domain, a thrombospondin type 1-like motif, a cysteinerich domain, and a spacer domain followed by two additional thrombospondin type 1-like motifs.

pathological processes including arthritis, atherosclerosis,
fibrosis, and wound healing. Since the first description
of prototype ADAMTS-1, there has been a quickly
expanding literature related to the definition of this gene
family and the proteins encoded (Porter et al., 2005). The
more the roles of ADAMTS family members are clearly
known in organogenesis, inflammation, and fertility,
the more articles are published on the role of ADAMTS
family members in angiogenesis and cancer (Kumar et
al., 2012). These extracellular multidomain enzymes can
be classified (Table 1) into subgroups in respect to their
functions as follows: procollagen processing (ADAMTS-2,
-3, and -14), proteoglycan degradation (ADAMTS-1, -4,
-5, -8, -9, and -15), blood coagulation (ADAMTS-13), and
cartilage oligomeric matrix protein (COMP) degradation
(ADAMTS-7 and -12). The functions of several neglected
ADAMTS members including ADAMTS-6, -16, -17, -18,
and -19 are still unknown (Porter et al., 2005; Kumar et
al., 2012).
3. Mechanisms of tissue regeneration
Reparation or healing is involved in the restoration
process of living tissue structure and gaining its function
after an injury; the reparation of a wound occurs as a result

of two types of reactions: regeneration by proliferation of
uninjured cells and maturation of tissue stem cell, and the
deposition of connective tissue to form a scar (Gurtner
et al., 2008). In all organ systems, the response of normal
mammalian tissue to an injury occurs in three overlapping
but distinctive stages: inflammation, new tissue formation,
and remodeling/reshaping. The sequence of events that
follows a myocardial infarction is remarkably similar to
the one seen in a spinal-cord injury (SCI). Interestingly,
the human liver is one of the few organs in the body to able
to regenerate up to 70% of itself without scar formation, as
demonstrated after partial hepatectomy (Hernandez-Gea
and Friedman, 2011). However, reparation by connective
tissue deposition consists of sequential stages following
tissue damage such as the inflammatory response,
angiogenesis, formation of granulation tissue, and
remodeling of connective tissue. Although regeneration
is a basic property of life, there are many varieties of
regeneration and posttraumatic tissue loss is associated
with a variety of physiological and pathological events
in the tissue regeneration process (Table 2). The loss of
cells through normal attrition is replaced on a continuous
basis by processes described as physiological regeneration
(Gurtner et al., 2008). The third stage of wound repair is

Table 1. Classification of ADAMTS proteoglycanases according to their functions.
Physiological function

Proteoglycanases

Aggrecanases

ADAMTS-1, -4, -5, -8, -9, -15, -16, and -18

Procollagen peptidases

ADAMTS-2, -3, and -14

COMP-ADAMTS

ADAMTS-7 and -12

GON-ADAMTS

ADAMTS-9 and -20

Anti-angiogenics

ADAMTS-1, -8, and -9

vWECP

ADAMTS-13

ORPHAN ADAMTS

ADAMTS-6, -10, -17, and -19
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Table 2. General consecutive physiopathological events series in tissue regeneration
process.
Trauma (mechanical, chemical, thermal…)
Localized posttraumatic ischemia and edema
Local inflammation and the removal of damaged tissues by phagocytosis
Activation of the cellular precursors of regeneration
Revascularization of the traumatized region
The extracellular matrix as a substrate for regeneration
Increase in the number of regenerating cells by proliferation
Differentiation of the regenerating tissue
Morphogenesis of the regenerating tissue
Functional restoration

implemented with matrix metalloproteinases secreted
by fibroblasts, macrophages, and endothelial cells, and
it strengthens the repaired tissue. Different patterns
of fibrosis growth have been accounted for in terms of
their etiology, the location of the injury, the source of the
fibrogenic cells involved, and the predominant fibrogenic
mechanism. On the other hand, multiple growth factors
initiate the cleavage of the cells assigned in reparation
(Gurtner et al., 2008; Hernandez-Gea and Friedman,
2011). Macrophages play a central role in reparation not
only by clearing off the disruptive agents and dead tissue
by means of providing growth factors for the proliferation
of various cells but also by secreting cytokines that
stimulate fibroblast proliferation and connective tissue
synthesis and deposition. Almost simultaneously, the
presence of macrophages is associated with the activation
of precursor cells for regeneration. Fibroblasts are the
prototypical mesenchymal cells that exist in many tissues
(e.g., liver, kidneys, skin, and lungs) and get activated
during repair processes (Kalluri and Zeisberg, 2006).
Epithelial-mesenchymal improvement has been associated
with tissue regeneration and fibrosis processes (Lee et al.,
2006). The ECM constitutes the largest component of the
damaged tissue and its synthesis is a key property of wound
healing, especially when there has been a significant loss of
tissue that inhibits closure. It is known that the ECM has
both structural and regulatory functions in respect to cells
and tissues. On the other hand, it has been proved that
ECM is particularly vital for the regulation of transforming
growth factor-beta (TGF-β), which is a pivotal agent in
fibrosis and inflammation. ECM deposition depends on
the balance between fibrogenic agents, metalloproteinases
(MMPs) that digest the ECM, and the tissue inhibitorsMMPs (TIMPs) (Page-McCaw et al., 2007; Hubmacher
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and Apte, 2013). Progress in understanding the effects of
the ECM thanks to proteinases has both provided a new
insight to cell regulation and identified useful disease
biomarkers, including ADAMTS proteinases.
4. ADAMTS expression in the nervous system and
related disorders
One of the characteristics of the central nervous
system (CNS) is that the ECM is composed mainly of
proteoglycans. It is thought to play important roles in the
CNS by modulating cell–matrix and cell–cell interactions,
and by binding to various cellular components. The ECM
is rich in hyaluronan, chondroitin sulfate proteoglycans
(CSPGs), lecticans (e.g., aggrecan, brevican, neurocan), link
proteins, and tenascins and can regulate cellular migration
and axonal growth, thus actively getting involved in the
development and maturation of the CNS (Zimmermann
and Dours-Zimmermann, 2008; Gottschall et al., 2015).
Studies on human diseased tissues and experimental
analyses using molecular biology techniques have
demonstrated the expression and function of ADAMTS
proteases in various tissues including the lungs, liver,
kidneys, and brain (Shiomi et al., 2010). Several members
of the ADAMTS family including ADAMTS-1, -4, -5, and
-9, or more precisely the proteoglycanases subgroup, are
characterized by their routine ability to degrade CSPGs
(Stanton et al., 2011). The CSPGs, a family of ECM
macromolecules, have been extensively investigated for
understanding their involvement in inflammation-induced
osteoarthritis (OA), and an increasing amount of evidence
indicates that they could have a crucial role physiologically
and pathologically in the CNS (Lemarchant et al., 2013).
Digestion of CSPGs is known to accelerate healing after
neural injury, therefore indicating the modulating of
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aggrecan function and cleavage related to perineuronal
net formation and maintenance in the CNS (Cicanic et al.,
2012). In addition, brain-derived link protein 1 (Bral1) is
a link protein that stabilizes the binding between lecticans
and hyaluronic acid and thus protects the ECM assembly
in the CNS (Morawski et al., 2012). ADAMTS members
are seen in the CNS (cortex, hippocampus, striatum, brain
stem, and spinal cord) and detected by means of direct
immunohistochemistry, western blot, and RT-PCR by
using ADAMTS-specific neoepitope antibodies to check
the changes in the fragments of various lectican substrates.
According to the recent literature, the proliferation of
lecticans appears to play an increasingly key role in neural
plasticity (Gottschall et al., 2015). After CNS injury,
CSPGs are rapidly upregulated within the glial scar and
cause both fusing and cleaning effects in the place where
the injury occurs. For example, their contribution to the
establishment of a dense glial scar initially constitutes
a protective barrier not only to limit the expansion of
damage but also to prevent the formation of a harmful
barrier to subsequent neurorepair and neuroplasticity
(Rolls et al., 2009). Comprehensive data indicate that
ADAMTS members increase their impacts on the therapy
of CNS disease, CNS disorders, and the restoration of
damaged tissues (Lemarchant et al., 2013; Gottschall et al.,
2015). Additionally, recent advancements in cellular and
molecular biology have provided a promising approach
for disc regeneration that focuses on the migration of
necessary cells to the degenerative disc (Wei et al., 2014).
In the degenerated disc the catabolic activity of MMPs,
disintegrins, ADAMTS members, and TIMPs alters,
resulting in enhanced breakdown of ECM proteins, unlike
that of normal disc tissue. These proteins facilitate tissue
remodeling in normal disc tissue, and at least they are
regulated to a certain extent by biomechanical pressure
stimuli (Pockert et al., 2009; Vo et al., 2013). In another
study, Tauchi et al. (2012) reported that for 7 days after
injury the spinal cord lysate shows a significant increase
in the aggrecan-degradation activity of ADAMTS-4, and
they claimed that improvements in axonal regeneration/
sprouting and subsequent functional recovery after SCI
were witnessed. Similarly, several studies suggest that
the ADAMTS members make a big contribution to SCI
recovery, helping the formation of a glial scar that is rich
in growth inhibitory molecules including lecticans, which
diminish during functional recovery. In the aftermath
of SCI, mRNA was upregulated, and this change was
accompanied by increasing proliferation of aggrecan,
brevican, and versican thanks to ADAMTS-1, -5, and -9
(Demircan et al., 2013). On the other hand, the expression
of key ECM components aggrecan and collagen decreases
in the degenerated disc tissues (Mern et al., 2013).

An increasing amount of evidence suggests that
ADAMTS members may play a role in neuroplasticity.
Lemarchant et al. (2014) claimed that the use of tPA, a drug
for the treatment of stroke, or of the recombinant human
ADAMTS-4 when it is applied in the subacute phase of
injuries in the CNS may promote plasticity and provide
long-term functional recovery. Overall, ADAMTS-4 may
be a potentially promising therapeutic agent in order
to increase plasticity and maintain functional recovery
in the aftermath of SCI, especially when it is delivered
soon after the injury. A study supporting this hypothesis
demonstrated that recombinant active ADAMTS-4
promotes neurite growth of cortical neurons in vitro
by degrading CSPGs via its proteolytic activity (Hamel
et al., 2008). Additionally, after testing ADAMTS-4
proteoglycanases in cultures of astrocytes, Hamel et al.
(2005) suggested that TGF-β may play a role in neural
plasticity and regeneration via its regulation of brevican
and the activity of the ADAMTS members. Furthermore,
Krstic et al. (2012) claimed that ADAMTS-4 and
ADAMTS-5, as the proteases being capable of cleaving
reelin and the extracellular molecules, are also involved
in synaptic plasticity and in neurodevelopment, which
induces learning and memory processes. Interestingly,
ADAMTS-induced cleavage of reelin is considered to
partly improve its reproduction during aging and to restore
the well-known synaptic plasticity defects in elderly CNS
tissues (Figure 2). Considering both of them together,
the majority of data suggest that the ADAMTS members
are involved in the activation of plasticity mechanisms
possibly on neurites and synapses and highlight that they
play a key role, which is not surprising since the CSPGs
can inhibit both neurite outgrowth and synaptic plasticity
(Lemarchant et al., 2013; Gottschall et al., 2015). However,
more studies are needed to determine whether or not
ADAMTS proteoglycanases have unnecessary expressions
and functions in the physiological and pathological CNS.
5. Effects of ADAMTS in the other pathological
conditions
ADAMTS proteases are not only utilized in ECM
assembly and degradation in morphogenesis, the
physiology of female reproductive system biology, and
many organ systems and processes, but they have been
incriminated in the pathological destruction of joint
tissues in rheumatoid arthritis and OA as well (Murphy
and Nagase, 2008; Demircan et al., 2014). These enzymes
degrade ECM macromolecules and modulate factors
governing cell behavior; therefore, they participate in
tissue reparation. Recent studies indicate that ADAMTS
members are likely to be beneficial in the understanding
of many diseases such as the pathogenesis of nervous
system disorders, arthritis, and liver fibrosis (Gurtner et
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Figure 2. A schematic presentation on the roles and importance of ADAMTS proteoglycanases in the CNS and neurological
disorders (CSPGs, chondroitin sulfate proteoglycans; PNN, perineuronal net; BBB, blood–brain barrier; *pathological role;
†described, ‡hypothetical).

al., 2008). Certain members of the ADAMTS family of
proteins have been demonstrated to cleave aggrecan in
vitro at the aggrecanase cleavage site. ADAMTS-4 and
ADAMTS-5 are closely related aggrecanases due to their
implications in proteolytic destruction of aggrecan in
osteoarthritic joint cartilage (Majumdar et al., 2007). In
addition, the inhibition of these enzymes is in line with
the prevention of aggrecan degradation in vitro (Malfait
et al., 2002). They are considered the primary enzymes
that are responsible for the cleavage of aggrecan; therefore,
they are potential targets for therapeutic intervention in
OA (Fosang and Little, 2008). In one study, Wylie et al.
(2012) investigated the distribution and activation of
ADAMTS-5, a vital aggrecanase in OA, in a mouse explant
model with inflammatory arthritis. The occurrence
of less severe osteoarthritis-like cartilage destruction
in syndecan-4 deficient mice and syndecan-4 specific
antibody-treated wild-type mice happens as a result of a
considerable decrease in ADAMTS-5 activity. Syndecan-4
regulates the activation of ADAMTS-5 via its direct
interaction with the protease and through regulating
mitogen-activated protein kinase (MAPK)-dependent
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synthesis of matrix metalloproteinase-3 (Echtermeyer
et al., 2009). On the other hand, the versican processing
with ADAMTS versicanases makes contributions to
muscle fiber formation. ADAMTS-5 was also proved
to contribute to versican proteolysis in the fibroblast
pericellular matrix and to reduce the versican amount in
ADAMTS-5-deficient fibroblasts, leading to a substantial
myofibroblast transition (Hattori et al., 2011). Establishing
the versican remodeling may increase the regenerative
capacity of muscle fiber fusion during regeneration
(Stupka et al., 2013). For example, ADAMTS-1 takes part
in versican proteolysis during myocardial compaction,
a process in which cardiac myocytes form a functional
myocardium during embryogenesis (Stankunas et al.,
2008). ADAMTS-7, another protease, associates with
granulin-epithelin precursor (GEP), a growth factor
implicating in tissue regeneration, tumorigenesis, and
inflammation. ADAMTS-7 functions as a new GEP
convertase and neutralizes GEP-stimulated endochondral
bone formation. In addition, COMP and GEP growth
factor, two binding partners of ADAMTS-7, were also
perceived to be primary intracellular factors in the growth
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plate chondrocytes. Diverse localization of ADAMTS-7
and GEP in various chondrocytes suggests that they
could play key roles at different levels in skeletogenesis
(Bai et al., 2009). Moreover, the fusion and cleavage of
COMP (a partner for ADAMTS-7 and -12) may also
make contributions to put forward the pathogenesis of
atherosclerotic disease. Wagsater et al. (2008) indicated that
not only are ADAMTS-4 and -8 expressed in macrophages
and in atherosclerotic plaques but also that the expression
is accelerated during atherogenesis. ADAMTS-13 is the
most extensively studied of all ADAMTS proteases. Its
essential substrate is von Willebrand’s factor (vWF), an
important component of the clotting cascade and vascular
basement membrane. Although the unclear contributions
of ADAMTS-13 in angiogenesis and neovascularization
are also reported, it has no direct relationship with the
ECM (Rodríguez-Manzaneque et al., 2015). It is known
that angiogenesis, the growth of new blood vessels from
preexisting vasculature, is very crucial in physiological
processes (growth and tissue remodeling in the menstrual
cycle) and pathological conditions such as cancer,
synovitis, and aberrant wound healing. Hsu et al. (2012)
reported that ADAMTS-4, like ADAMTS-1, is expressed
by endothelial cells, and it has antiangiogenic activity.
Previously, Malfait et al. (2002) claimed that
ADAMTS-4 and ADAMTS-5 represent a potential target
for the treatment of OA, and then Larkin et al. (2015)
generated and tested the first selective ADAMTS-5
inhibitor named GSK2394002. They developed fully
selective high-affinity monoclonal antibodies (mAb) for
inhibition of aggrecanase activity, which is the hallmark
of OA. Based on their studies, ADAMTS-5 is a significant
proteoglycanase involved in cartilage degradation in
human OA patients. Humanized mAb dose-dependently
inhibited ADAMTS-5-mediated proteolysis of aggrecan
and brevican via an allosteric lock mechanism. They also
found that the mice treated with ADAMTS-5 mAb were
protected from mechanical allodynia (a pain-related
behavior) during a medial meniscus model of OA. In this
way, ADAMTS-5 may be candidate of pain-related factors
in OA and provides the first evidence for the treatment of
both cartilage regeneration and pain symptoms caused
by OA-associated algesia in OA. All these results suggest
that ADAMTS proteases could be beneficial in the therapy
of chronic degenerative diseases, not only because of

its protective effects on the matrix but also because it
has no interference with chondrogenesis. Thanks to its
regenerative impacts it could make regenerative processes
based on endogenous progenitor cells come into action.
6. Conclusion
During the last 15 years studies have demonstrated that
ADAMTS proteinases are involved in a surprisingly
diverse range of biological processes, from organogenesis
to fertility and from regulation of angiogenesis to blood
coagulation, with clear links to ECM assembly and ECM
degradation. In the approach of investigative molecular
mechanisms, they have been noticed to have regulatory
functions on propeptide processing and posttranslational
modification. Recent clinical and laboratory data show that
not only do ADAMTS proteases play a key role in tissue
reparation but that the destruction of ECM components
impairs wound healing processes as well. The role of the
ADAMTS members in the CNS continues to expand;
more and more evidence demonstrates that they have a
crucial role in neuroplasticity and neurorepair. ADAMTS
family members, when taken together naturally, may be
utilized to support other therapies for CNS injuries and
neurodegenerative disorders such as Alzheimer disease.
In addition to their proteolytic functions, ADAMTS
proteases can potentially accelerate tissue regeneration
(after the destruction of joint tissues and vascularrelated damages) in the field of restorative biology and
medicine. In spite of the management of larger lesions
by using tissue engineering, many cartilage defects
may be repaired, providing biologic solutions thanks to
cartilage regeneration in the near future. Although many
investigations have been carried out regarding ADAMTS
in a wide spectrum of fields ranging from CNS disorders
and arthritis to tumor pathobiology in recent years, more
mechanistic and functional studies are required to be
conducted to fully understand the benefits of the enzyme
dynamics.
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